Tender Details

Country: USA
Summary: THERAKOS CELLEX Photopheresis System Procedural Kits
UST Ref No: 121590505
Deadline: 05 Jul 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 25-007707
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
THERAKOS CELLEX Photopheresis System Procedural Kits

Product Service Code: 6650- Optical Instruments, Test Equipment, Components and Accessories
NAICS Code: 325413: In Vitro Diagnostic Substance Manufacturing small business 1,250 average number of employees.
Place of Performance: Bethesda, MD 20892
POTS: 25-007707

Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health, Office of Purchasing and Contracts on behalf of Department of Transfusion Medicine (DTM) intends to award a firm-fixed price contract to Therakos for quantity five (5) cases of Cellex USA Kits needed for emergent Extracorporeal Photopheresis kits used for patient care on a sole source basis located at Therakos Inc. 675 James S Mcdonnell Blvd Hazelwood, Missouri 63042 to procure this kit.

LINE # List of Equipment: Catalog # Qty
01 Cellex USA Kits CLXUSA 5.00

Cellex USA Kits are needed for Extracorporeal Photopheresis (ECP) procedures for Clinical Center patients. These kits are only manufactured and sold by the Cellex equipment manufacturer Therakos. These kits are for very rare photopheresis procedures that are not done regularly. The request for these procedures is based on treatment plans that vary based on the condition of the patient(s) and are communicated to the primary care team as needed. It is used for to draw patient-s blood, and the white blood cells (including T cells) are separated from the rest of the blood using centrifugation, and the separated white blood cells are then exposed to Ultraviolent (UVA) light, which damages the DNA of the treated cells, rendering them apoptotic (programmed cell death). There are no stock large quantities due to the high costs, short expiration date, and the unpredictability of the need. In addition, due to the astronomical costs, it would not be ide...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

THERAKOS CELLEX Photopheresis System Procedural Kits - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for THERAKOS CELLEX Photopheresis System Procedural Kits. This tender is published on USARFP under UST Ref No: 121590505 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-05.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.